IP Library Granted Patent US 7,135,571
Granted Patent B2
US 7,135,571 · App. 10/160,883 · Granted Nov 14, 2006

Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof

Assignee: Aventis Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,135,571
App. No.
10/160,883
Granted
Nov 14, 2006
Kind
B2
Abstract

The present invention is related to novel processes for preparing anhydrous and hydrated forms of piperidine derivatives, polymorphs and pseudomorphs thereof of the formulas which are useful as antihistamines, antiallergic agents and bronchodilators.

Claims (1)

1. Form II hydrated 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic acid hydrochloride.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2010
From: AVENTIS HOLDINGS INC.
To: AVENTISUB II INC.
Reel/Frame 024006/0487 →
CHANGE OF NAME Recorded Nov 29, 2007
From: HMR PHARMA INC.
To: AVENTIS HOLDINGS INC.
Reel/Frame 020174/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2007
From: AVENTIS PHARMACEUTICALS INC.
To: HMR PHARMA INC.
Reel/Frame 020119/0606 →
MERGER Recorded Apr 17, 2006
From: MARION MERRELL DOW INC.
To: HOECHST MARION ROUSSEL, INC.
Reel/Frame 017478/0461 →
CHANGE OF NAME Recorded Apr 17, 2006
From: HOECHST MARION ROUSSEL, INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 017478/0526 →
Continuity (7)
Continuation 0980347600 · Mar 9, 2001
Continuation 0921316100 · Dec 17, 1998
Continuation 0881564100 · Mar 13, 1997
Continuation 0843967300 · May 12, 1995
Division 0841716100 · Apr 11, 1995
Continuation In Part 0824573100 · May 18, 1994
Related Publication 20020193601A1 · Dec 19, 2002